Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

HIV infection and obesity: where did all the wasting go?

Tate T, Willig AL, Willig JH, Raper JL, Moneyham L, Kempf MC, Saag MS, Mugavero MJ.

Antivir Ther. 2012;17(7):1281-9. doi: 10.3851/IMP2348. Epub 2012 Sep 5.

2.

Rising Obesity Prevalence and Weight Gain Among Adults Starting Antiretroviral Therapy in the United States and Canada.

Koethe JR, Jenkins CA, Lau B, Shepherd BE, Justice AC, Tate JP, Buchacz K, Napravnik S, Mayor AM, Horberg MA, Blashill AJ, Willig A, Wester CW, Silverberg MJ, Gill J, Thorne JE, Klein M, Eron JJ, Kitahata MM, Sterling TR, Moore RD; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD).

AIDS Res Hum Retroviruses. 2016 Jan;32(1):50-8. doi: 10.1089/aid.2015.0147. Epub 2015 Sep 9.

3.

High prevalence of being Overweight and Obese HIV-infected persons, before and after 24 months on early ART in the ANRS 12136 Temprano Trial.

Guehi C, Badjé A, Gabillard D, Ouattara E, Koulé SO, Moh R, Ekouevi D, Ahibo H, N'Takpé JB, Menan GK, Deschamps N, Lecarrou J, Eholié S, Anglaret X, Danel C.

AIDS Res Ther. 2016 Feb 25;13:12. doi: 10.1186/s12981-016-0094-y. eCollection 2016.

4.

Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D study.

Achhra AC, Mocroft A, Reiss P, Sabin C, Ryom L, de Wit S, Smith CJ, d'Arminio Monforte A, Phillips A, Weber R, Lundgren J, Law MG; D:A:D Study Group.

HIV Med. 2016 Apr;17(4):255-68. doi: 10.1111/hiv.12294. Epub 2015 Jul 28.

PMID:
26216031
5.

A tale of 2 epidemics: the intersection between obesity and HIV infection in Philadelphia.

Amorosa V, Synnestvedt M, Gross R, Friedman H, MacGregor RR, Gudonis D, Frank I, Tebas P.

J Acquir Immune Defic Syndr. 2005 Aug 15;39(5):557-61.

PMID:
16044007
6.

Short communication: from wasting to obesity: initial antiretroviral therapy and weight gain in HIV-infected persons.

Lakey W, Yang LY, Yancy W, Chow SC, Hicks C.

AIDS Res Hum Retroviruses. 2013 Mar;29(3):435-40. doi: 10.1089/AID.2012.0234. Epub 2012 Nov 7.

7.

Increased body mass index does not alter response to initial highly active antiretroviral therapy in HIV-1-infected patients.

Tedaldi EM, Brooks JT, Weidle PJ, Richardson JT, Baker RK, Buchacz K, Moorman AC, Wood KC, Holmberg SD; HOPS Investigators.

J Acquir Immune Defic Syndr. 2006 Sep;43(1):35-41.

PMID:
16885779
8.

Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.

Verweel G, van Rossum AM, Hartwig NG, Wolfs TF, Scherpbier HJ, de Groot R.

Pediatrics. 2002 Feb;109(2):E25.

PMID:
11826235
9.

Longitudinal association between BMI at diagnosis and HIV disease progression.

Johnson KD, Cai B, Duffus W, White K, Smieja M, Divya A, Merchant AT.

AIDS Behav. 2014 Nov;18(11):2249-57. doi: 10.1007/s10461-014-0805-0.

PMID:
24880700
10.

Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiation.

Grant PM, Kitch D, McComsey GA, Dube MP, Haubrich R, Huang J, Riddler S, Tebas P, Zolopa AR, Collier AC, Brown TT.

Clin Infect Dis. 2013 Nov;57(10):1483-8. doi: 10.1093/cid/cit538. Epub 2013 Aug 13.

11.

[Overweight, obesity and underweight in HIV infected patients].

Kwiatkowska W, Knysz B, Drelichowska-Durawa J, Czarnecki M, Gasiorowski J, Biłyk E, Karczewski M, Witkiewicz W.

Przegl Lek. 2013;70(3):113-7. Polish.

PMID:
24003663
12.
13.

Weight change after antiretroviral therapy and mortality.

Yuh B, Tate J, Butt AA, Crothers K, Freiberg M, Leaf D, Logeais M, Rimland D, Rodriguez-Barradas MC, Ruser C, Justice AC.

Clin Infect Dis. 2015 Jun 15;60(12):1852-9. doi: 10.1093/cid/civ192. Epub 2015 Mar 11.

14.

Relationship between Body Mass Index and Mortality in HIV-Infected HAART Users in the Women's Interagency HIV Study.

Sharma A, Hoover DR, Shi Q, Gustafson D, Plankey MW, Hershow RC, Tien PC, Golub ET, Anastos K.

PLoS One. 2015 Dec 23;10(12):e0143740. doi: 10.1371/journal.pone.0143740. eCollection 2015.

15.

Weight status and associated factors among HIV infected people on antiretroviral therapy in rural Dikgale, Limpopo, South Africa.

Mashinya F, Alberts M, Colebunders R, Van Geertruyden JP.

Afr J Prim Health Care Fam Med. 2016 Nov 29;8(1):e1-e8. doi: 10.4102/phcfm.v8i1.1230.

16.

Body mass index and the risk of incident noncommunicable diseases after starting antiretroviral therapy.

Koethe JR, Jenkins CA, Turner M, Bebawy S, Shepherd BE, Wester CW, Sterling TR.

HIV Med. 2015 Jan;16(1):67-72. doi: 10.1111/hiv.12178. Epub 2014 Sep 17.

17.

Trends and risk factors for obesity among HIV positive Nigerians on antiretroviral therapy.

Ezechi LO, Musa ZA, Otobo VO, Idigbe IE, Ezechi OC.

Ceylon Med J. 2016 Jun;61(2):56-62. doi: 10.4038/cmj.v61i2.8300.

18.

Association of hypertension and obesity with HIV and antiretroviral therapy in a rural tertiary health center in Nigeria: a cross-sectional cohort study.

Ogunmola OJ, Oladosu OY, Olamoyegun AM.

Vasc Health Risk Manag. 2014 Mar 18;10:129-37. doi: 10.2147/VHRM.S58449. eCollection 2014.

19.

Inflammation and Change in Body Weight With Antiretroviral Therapy Initiation in a Multinational Cohort of HIV-Infected Adults.

Mave V, Erlandson KM, Gupte N, Balagopal A, Asmuth DM, Campbell TB, Smeaton L, Kumarasamy N, Hakim J, Santos B, Riviere C, Hosseinipour MC, Sugandhavesa P, Infante R, Pillay S, Cardoso SW, Tripathy S, Mwelase N, Berendes S, Andrade BB, Thomas DL, Bollinger RC, Gupta A; ACTG PEARLS and NWCS 319 Study Team.

J Infect Dis. 2016 Jul 1;214(1):65-72. doi: 10.1093/infdis/jiw096. Epub 2016 Mar 8.

20.

Changes in Body Mass Index Following HAART Initiation among HIV-Infected Women in the Women's Interagency HIV Study.

Sharma A, Bynum SA, Schneider MF, Cox C, Tien PC, Hershow RC, Gustafson D, Plankey MW.

J AIDS Clin Res. 2014;5. pii: 1000323.

Supplemental Content

Support Center